Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna Flavia Cantone"'
Autor:
Carlo Maria Bellanca, Egle Augello, Giulia Di Benedetto, Chiara Burgaletto, Anna Flavia Cantone, Giuseppina Cantarella, Renato Bernardini, Riccardo Polosa, the DiaSmokeFree Working Group, Agostino Di Ciaula, Tabinda Dugal, Andre Kengne, Phuong Le Dinh, Anoop Misra, Syed Abbas Raza, Cristina Russo, Noel Somasundaram, Roberta Sammut, Magda Walicka
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Currently 1.3 billion individuals globally engage in smoking, leading to significant morbidity and mortality, particularly among diabetic patients. There is urgent need for a better understanding of how smoking influences antidiabetic treatment effic
Externí odkaz:
https://doaj.org/article/4bb1a32092714745836cb116f40fdd24
Autor:
Antonio Munafò, Anna Flavia Cantone, Giulia Di Benedetto, Sebastiano Alfio Torrisi, Chiara Burgaletto, Carlo Maria Bellanca, Gabriella Gaudio, Giuseppe Broggi, Rosario Caltabiano, Gian Marco Leggio, Renato Bernardini, Giuseppina Cantarella
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Alzheimer’s disease (AD) is the most common neurodegenerative disorder affecting the elderly population worldwide. Due to the multifactorial nature of the disease, involving impairment of cholinergic neurotransmission and immune syste
Externí odkaz:
https://doaj.org/article/2bc260aaa7b44b5ab9349522287a2481
Autor:
Anna Flavia Cantone, Chiara Burgaletto, Giulia Di Benedetto, Anna Pannaccione, Agnese Secondo, Carlo Maria Bellanca, Egle Augello, Antonio Munafò, Paola Tarro, Renato Bernardini, Giuseppina Cantarella
Publikováno v:
Cells, Vol 13, Iss 4, p 309 (2024)
Alzheimer’s disease (AD), marked by cognitive impairment, predominantly affects the brain regions regulated by cholinergic innervation, such as the cerebral cortex and hippocampus. Cholinergic dysfunction, a key contributor to age-related cognitive
Externí odkaz:
https://doaj.org/article/0074e566984743d1b80f60d887a65765
Autor:
Carlo Maria Bellanca, Egle Augello, Anna Flavia Cantone, Rosaria Di Mauro, Giuseppe Antonino Attaguile, Vincenza Di Giovanni, Guido Attilio Condorelli, Giulia Di Benedetto, Giuseppina Cantarella, Renato Bernardini
Publikováno v:
Pharmaceuticals, Vol 16, Iss 11, p 1542 (2023)
The European Medicine Agency (EMA) has defined Adverse Drug Reactions (ADRs) as “a noxious and unintended response to a medicine”, not including poisoning, accidental, or intentional overdoses. The ADR occurrence differs based on the approach ado
Externí odkaz:
https://doaj.org/article/9d5abb93c0234a11ad5956bd8ec266f5